Amplify YieldShares Oil Hedged MLP Income ETF (AMLX) News

Amplify YieldShares Oil Hedged MLP Income ETF (AMLX): $1.83

0.00 (0.00%)

POWR Rating

Component Grades

Buy & Hold

F

Peer

D

Add AMLX to Watchlist
Sign Up

Category: MLP ETFs

Category

B

Ranked


in category

Filter AMLX News Items

AMLX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

AMLX News Highlights

  • For AMLX, its 30 day story count is now at 3.
  • Over the past 15 days, the trend for AMLX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about AMLX are PAY.

Latest AMLX News From Around the Web

Below are the latest news stories about AMYLYX PHARMACEUTICALS INC that investors may wish to consider to help them evaluate AMLX as an investment opportunity.

Is Amylyx (AMLX) Stock a Solid Choice Right Now?

Amylyx (AMLX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Yahoo | December 26, 2023

Amylyx Pharmaceuticals Announces First Participant Dosed in the Global Phase 3 ORION Study of AMX0035 in Progressive Supranuclear Palsy (PSP)

CAMBRIDGE, Mass., December 22, 2023--Amylyx Pharmaceuticals Announces First Participant Dosed in the Global Phase 3 ORION Study of AMX0035 in Progressive Supranuclear Palsy (PSP)

Yahoo | December 22, 2023

Implied Volatility Surging for Amylyx (AMLX) Stock Options

Investors need to pay close attention to Amylyx (AMLX) stock based on the movements in the options market lately.

Yahoo | December 11, 2023

Amylyx Pharmaceuticals Announces Publication of Data Showing the Effect of AMX0035 on Plasma Neuroinflammatory Biomarkers in ALS

CAMBRIDGE, Mass., December 04, 2023--Amylyx Pharmaceuticals Announces Publication of Data Showing the Effect of AMX0035 on Plasma Neuroinflammatory Biomarkers in ALS

Yahoo | December 4, 2023

Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., November 29, 2023--Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo | November 29, 2023

3 Top-Rated Biotech Stocks That Analysts Are Loving Now

Investing in biotech stocks can be tricky, but analysts have bullish outlooks on these three, promising companies.

Chris Markoch on InvestorPlace | November 28, 2023

Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as Chief Medical Officer

CAMBRIDGE, Mass., November 28, 2023--Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as Chief Medical Officer

Yahoo | November 28, 2023

RELYVRIO® and AMX0114 Data to be Presented at 34th International Symposium on ALS/MND

CAMBRIDGE, Mass., November 27, 2023--RELYVRIO® and AMX0114 Data to be Presented at 34th International Symposium on ALS/MND

Yahoo | November 27, 2023

Amylyx Pharmaceuticals to Participate at the 6th Annual Evercore ISI HealthCONx Conference

CAMBRIDGE, Mass., November 21, 2023--Amylyx Pharmaceuticals to Participate at the 6th Annual Evercore ISI HealthCONx Conference

Yahoo | November 21, 2023

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2023 Earnings Call Transcript

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Good morning. My name is Keith, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions]. […]

Yahoo | November 12, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!